371 filings
6-K
BFFTF
Biofrontera AG
9 Mar 22
Biofrontera files Form 15F to suspend SEC Reporting Requirements and starts trading Level I ADS program on US OTC market
5:53pm
6-K
BFFTF
Biofrontera AG
24 Feb 22
Current report (foreign)
2:13pm
6-K
BFFTF
Biofrontera AG
22 Feb 22
Current report (foreign)
10:00am
6-K
BFFTF
Biofrontera AG
14 Feb 22
Current report (foreign)
12:00am
6-K
BFFTF
Biofrontera AG
1 Feb 22
Current report (foreign)
10:00am
6-K
gab1313
13 Jan 22
Biofrontera announces preliminary revenue figures for the full year 2021
9:26am
6-K
px6 ag3qp
29 Dec 21
Current report (foreign)
6:20am
6-K
phsd61corsoh s0
14 Dec 21
Annual General Meeting
2:24pm
6-K
1c2hx
13 Dec 21
Current report (foreign)
10:22am
6-K
u0qs zmxs466v
8 Dec 21
Biofrontera AG obtains notice of allowance for US patent on PDT-lamp and treatment method
8:43am
6-K
vx5z96ee
2 Dec 21
Biofrontera obtains notice of allowance for US patent on innovative illumination protocol
10:01am
6-K
1q70nzb4p6 jz
2 Dec 21
Biofrontera AG announces timing of the departure of the CEO
7:37am
6-K
h0yeb20g67ajp
2 Dec 21
Current report (foreign)
12:00am
6-K
uf1zab 3sg9h6g
30 Nov 21
Addition to the agenda of the Annual General Meeting on 14 December 2021 pursuant to section 122 (2) AktG at the request of a shareholder
12:21pm
6-K
yhzmlzwjw866bezyo
29 Nov 21
Current report (foreign)
1:13pm
6-K
yhqxfuji99la37r1
29 Nov 21
Current report (foreign)
10:23am
6-K
0vmii852 3wkg
24 Nov 21
Invitation to the Annual General Meeting
10:12am
6-K
n1ntj
19 Nov 21
Biofrontera AG announces mediation results
11:02am
6-K
ex6280n9jz59v
18 Nov 21
Quarterly report Q3 2021
12:00am
6-K
2irps357qn5hrevlfx
16 Nov 21
Biofrontera AG announces initiation of clinical studies
11:40am